Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Potent, broad-spectrum antibacterial compounds developed at Daiichi

July 21, 1998

NeXstar initiates third phase II MiKasome trial

July 21, 1998

Sankyo presents new antifungal agents for Candida infections

July 20, 1998

Antibacterial agent of microbial origin discovered by Sankyo

July 20, 1998

Pola discloses new antifungal agents

July 17, 1998

Locally applied fusafungine for rhinitis and sinusitis

July 17, 1998

Cephalosporins described by Roche for Gram-positive infections

July 16, 1998

Novel antimicrobial lipid compounds for preventing STDs

July 16, 1998

New semisynthetic macrolide antibiotics designed by Pliva

July 15, 1998

NeXstar initiates second part of MiKasome phase II trial and reports preliminary findings

July 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...